Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
11.94
+0.73 (6.51%)
Mar 9, 2026, 1:07 PM EDT - Market open
Generate Biomedicines Market Cap
Generate Biomedicines has a market cap or net worth of $1.52 billion as of March 9, 2026.
Market Cap
1.52B
Enterprise Value
1.38B
1-Year Change
n/a
Ranking
Category
Stock Price
$11.94
Market Cap Chart
Since the IPO on February 27, 2026, Generate Biomedicines's market cap has decreased from $2.04B to $1.52B, a decrease of -25.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.43B | -29.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kodiak Sciences | 1.54B |
| Vir Biotechnology | 1.53B |
| Ardelyx | 1.52B |
| Biohaven | 1.49B |
| Capricor Therapeutics | 1.44B |
| Rapport Therapeutics | 1.44B |
| MBX Biosciences | 1.44B |
| Monte Rosa Therapeutics | 1.41B |